electroCore (ECOR) Projected to Post Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECOR) is expected to be releasing its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect electroCore to post earnings of ($0.35) per share for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:00 PM ET.

electroCore Trading Down 2.1%

ECOR stock opened at $7.61 on Wednesday. The company has a market capitalization of $60.88 million, a PE ratio of -4.45 and a beta of 0.48. electroCore has a 12-month low of $4.16 and a 12-month high of $15.68. The business’s fifty day moving average price is $6.13 and its 200 day moving average price is $5.44.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ECOR. Two Sigma Investments LP grew its holdings in electroCore by 20.8% during the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after acquiring an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of electroCore during the 1st quarter worth $153,000. Jane Street Group LLC lifted its position in shares of electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after purchasing an additional 19,599 shares during the last quarter. DRW Securities LLC acquired a new position in shares of electroCore during the fourth quarter worth $264,000. Finally, NewEdge Advisors LLC increased its holdings in electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after buying an additional 145,047 shares during the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Wall Street Zen upgraded shares of electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Zacks Research cut shares of electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. HC Wainwright cut their target price on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, January 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a report on Monday, December 29th. Finally, Brookline Capital Acquisition upgraded shares of electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $22.00.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.